$CWBC
Community West Bancshares Stock $cwbc

$cwbc Overview Financials Valuation SEC Filings Company Website

2021 Q1 Form 10-Q Financial Statement

#000112737121000063 Filed on May 05, 2021

Income Statement

Concept	2021 Q1	2020 Q1
Revenue	$17.85M	$16.51M
YoY Change	8.12%	1.33%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$1.850M	$1.180M
YoY Change	56.78%	-36.56%
% of Gross Profit
Operating Expenses
YoY Change
Operating Profit
YoY Change
Interest Expense	$292.0K	$477.0K
YoY Change	-38.78%	5.07%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income	$9.966M	$9.117M
YoY Change	9.31%	27.17%
Income Tax	$2.487M	$2.494M
% Of Pretax Income	24.95%	27.36%
Net Earnings	$7.479M	$6.623M
YoY Change	12.92%	26.97%
Net Earnings / Revenue	41.91%	40.12%
Basic Earnings Per Share	$0.60	$0.52
Diluted Earnings Per Share	$0.60	$0.52
COMMON SHARES
Basic Shares Outstanding	12.50M shares	12.73M shares
Diluted Shares Outstanding	12.55M shares	12.78M shares

Balance Sheet

Concept	2021 Q1	2020 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents	$214.8M	$36.16M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment	$8.349M	$7.410M
YoY Change	12.67%	-8.47%
Goodwill	$53.78M	$53.78M
YoY Change	0.0%	0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets	$2.201B	$1.619B
YoY Change	35.95%	3.48%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$31.10M	$44.20M
YoY Change	-29.64%	37.69%
Accrued Expenses		$6.100M
YoY Change		-24.69%
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$31.10M	$44.20M
YoY Change	-29.64%	37.69%
LONG-TERM LIABILITIES
Long-Term Debt	$5.200M	$5.200M
YoY Change	0.0%	0.0%
Other Long-Term Liabilities	$16.70M	$9.300M
YoY Change	79.57%	-10.58%
Total Long-Term Liabilities	$5.200M	$5.200M
YoY Change	0.0%	0.0%
TOTAL LIABILITIES
Total Short-Term Liabilities	$31.10M	$44.20M
Total Long-Term Liabilities	$5.200M	$5.200M
Total Liabilities	$1.959B	$1.400B
YoY Change	39.91%	4.73%
SHAREHOLDERS EQUITY
Retained Earnings	$156.9M	$141.1M
YoY Change	11.13%	13.7%
Common Stock	$79.73M	$78.85M
YoY Change	1.11%	-22.99%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$241.8M	$218.7M
YoY Change
Total Liabilities & Shareholders Equity	$2.201B	$1.619B
YoY Change	35.95%	3.48%

Cashflow Statement

Concept	2021 Q1	2020 Q1
OPERATING ACTIVITIES
Net Income	$7.479M	$6.623M
YoY Change	12.92%	26.97%
Depreciation, Depletion And Amortization	$1.850M	$1.180M
YoY Change	56.78%	-36.56%
Cash From Operating Activities	$6.379M	$5.931M
YoY Change	7.55%	-14.07%
INVESTING ACTIVITIES
Capital Expenditures	$344.0K	$32.00K
YoY Change	975.0%	-75.94%
Acquisitions
YoY Change
Other Investing Activities	-$59.85M	-$27.42M
YoY Change	118.27%	162.14%
Cash From Investing Activities	-$60.19M	-$27.45M
YoY Change	119.24%	159.27%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$0.00	$11.05M
YoY Change	-100.0%	489.75%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$198.4M	$5.111M
YoY Change	3781.3%	21.84%
NET CHANGE
Cash From Operating Activities	$6.379M	$5.931M
Cash From Investing Activities	-$60.19M	-$27.45M
Cash From Financing Activities	$198.4M	$5.111M
Net Change In Cash	$144.6M	-$16.41M
YoY Change	-980.84%	-3330.71%
FREE CASH FLOW
Cash From Operating Activities	$6.379M	$5.931M
Capital Expenditures	$344.0K	$32.00K
Free Cash Flow	$6.035M	$5.899M
YoY Change	2.31%	-12.85%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2021Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001127371
CY2021Q1	dei	Amendment Flag AmendmentFlag	false
CY2021Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2021Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2021
CY2021Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2021Q1	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2021Q1	us-gaap	Loans And Leases Receivable Allowance LoansAndLeasesReceivableAllowance	12056000	USD
CY2020Q4	us-gaap	Loans And Leases Receivable Allowance LoansAndLeasesReceivableAllowance	12915000	USD
CY2021Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2020Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2021Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2020Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2021Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2020Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2021Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	80000000	shares
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	80000000	shares
CY2021Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	12524609	shares
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	12509848	shares
CY2021Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	12524609	shares
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	12509848	shares
CY2021Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0
CY2021Q1	cvcy	Financing Receivable Modifications Subsequent Defaults During Period Number Of Contracts FinancingReceivableModificationsSubsequentDefaultsDuringPeriodNumberOfContracts	0	contract
CY2020Q1	cvcy	Financing Receivable Modifications Subsequent Defaults During Period Number Of Contracts FinancingReceivableModificationsSubsequentDefaultsDuringPeriodNumberOfContracts	0	contract
CY2021Q1	dei	Document Type DocumentType	10-Q
CY2021Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2021Q1	dei	Document Period End Date DocumentPeriodEndDate	2021-03-31
CY2021Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2021Q1	dei	Entity File Number EntityFileNumber	000-31977
CY2021Q1	dei	Entity Registrant Name EntityRegistrantName	CENTRAL VALLEY COMMUNITY BANCORP
CY2021Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	CA
CY2021Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	77-0539125
CY2021Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	7100 N. Financial Dr., Suite 101
CY2021Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Fresno
CY2021Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
CY2021Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	93720
CY2021Q1	dei	City Area Code CityAreaCode	559
CY2021Q1	dei	Local Phone Number LocalPhoneNumber	298-1775
CY2021Q1	dei	Security12b Title Security12bTitle	Common Stock, no par value
CY2021Q1	dei	Trading Symbol TradingSymbol	CVCY
CY2021Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2021Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2021Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2021Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2021Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2021Q1	dei	Entity Shell Company EntityShellCompany	false
CY2021Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	12529609	shares
CY2021Q1	us-gaap	Cash And Due From Banks CashAndDueFromBanks	31083000	USD
CY2020Q4	us-gaap	Cash And Due From Banks CashAndDueFromBanks	34175000	USD
CY2021Q1	us-gaap	Interest Bearing Deposits In Banks InterestBearingDepositsInBanks	183758000	USD
CY2020Q4	us-gaap	Interest Bearing Deposits In Banks InterestBearingDepositsInBanks	36103000	USD
CY2021Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	214841000	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	70278000	USD
CY2021Q1	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	768719000	USD
CY2020Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	710092000	USD
CY2021Q1	us-gaap	Available For Sale Securities Equity Securities AvailableForSaleSecuritiesEquitySecurities	7500000	USD
CY2020Q4	us-gaap	Available For Sale Securities Equity Securities AvailableForSaleSecuritiesEquitySecurities	7634000	USD
CY2021Q1	us-gaap	Loans And Leases Receivable Net Reported Amount LoansAndLeasesReceivableNetReportedAmount	1078284000	USD
CY2020Q4	us-gaap	Loans And Leases Receivable Net Reported Amount LoansAndLeasesReceivableNetReportedAmount	1089432000	USD
CY2021Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	8349000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	8228000	USD
CY2021Q1	us-gaap	Bank Owned Life Insurance BankOwnedLifeInsurance	28886000	USD
CY2020Q4	us-gaap	Bank Owned Life Insurance BankOwnedLifeInsurance	28713000	USD
CY2021Q1	us-gaap	Federal Home Loan Bank Stock FederalHomeLoanBankStock	5595000	USD
CY2020Q4	us-gaap	Federal Home Loan Bank Stock FederalHomeLoanBankStock	5595000	USD
CY2021Q1	us-gaap	Goodwill Goodwill	53777000	USD
CY2020Q4	us-gaap	Goodwill Goodwill	53777000	USD
CY2021Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1009000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1183000	USD
CY2021Q1	cvcy	Accrued Interest Receivable And Other Assets AccruedInterestReceivableAndOtherAssets	33563000	USD
CY2020Q4	cvcy	Accrued Interest Receivable And Other Assets AccruedInterestReceivableAndOtherAssets	29164000	USD
CY2021Q1	us-gaap	Assets Assets	2200523000	USD
CY2020Q4	us-gaap	Assets Assets	2004096000	USD
CY2021Q1	us-gaap	Noninterest Bearing Deposit Liabilities Domestic NoninterestBearingDepositLiabilitiesDomestic	885654000	USD
CY2020Q4	us-gaap	Noninterest Bearing Deposit Liabilities Domestic NoninterestBearingDepositLiabilitiesDomestic	824889000	USD
CY2021Q1	us-gaap	Interest Bearing Deposit Liabilities Domestic InterestBearingDepositLiabilitiesDomestic	1036749000	USD
CY2020Q4	us-gaap	Interest Bearing Deposit Liabilities Domestic InterestBearingDepositLiabilitiesDomestic	897821000	USD
CY2021Q1	us-gaap	Deposits Deposits	1922403000	USD
CY2020Q4	us-gaap	Deposits Deposits	1722710000	USD
CY2021Q1	us-gaap	Junior Subordinated Debenture Owed To Unconsolidated Subsidiary Trust JuniorSubordinatedDebentureOwedToUnconsolidatedSubsidiaryTrust	5155000	USD
CY2020Q4	us-gaap	Junior Subordinated Debenture Owed To Unconsolidated Subsidiary Trust JuniorSubordinatedDebentureOwedToUnconsolidatedSubsidiaryTrust	5155000	USD
CY2021Q1	cvcy	Accrued Interest Payable And Other Liabilities AccruedInterestPayableAndOtherLiabilities	31120000	USD
CY2020Q4	cvcy	Accrued Interest Payable And Other Liabilities AccruedInterestPayableAndOtherLiabilities	31210000	USD
CY2021Q1	us-gaap	Liabilities Liabilities	1958678000	USD
CY2020Q4	us-gaap	Liabilities Liabilities	1759075000	USD
CY2021Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2020Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2021Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2020Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2021Q1	us-gaap	Common Stock Value CommonStockValue	79732000	USD
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	79416000	USD
CY2021Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	156851000	USD
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	150749000	USD
CY2021Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	5262000	USD
CY2020Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	14856000	USD
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	241845000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	245021000	USD
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2004096000	USD
CY2021Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2200523000	USD
CY2021Q1	us-gaap	Interest And Fee Income Loans And Leases InterestAndFeeIncomeLoansAndLeases	13765000	USD
CY2020Q1	us-gaap	Interest And Fee Income Loans And Leases InterestAndFeeIncomeLoansAndLeases	12898000	USD
CY2021Q1	us-gaap	Interest Income Deposits With Financial Institutions InterestIncomeDepositsWithFinancialInstitutions	32000	USD
CY2020Q1	us-gaap	Interest Income Deposits With Financial Institutions InterestIncomeDepositsWithFinancialInstitutions	183000	USD
CY2021Q1	us-gaap	Interest Income Securities Taxable InterestIncomeSecuritiesTaxable	2733000	USD
CY2020Q1	us-gaap	Interest Income Securities Taxable InterestIncomeSecuritiesTaxable	3266000	USD
CY2021Q1	us-gaap	Interest Income Securities Tax Exempt InterestIncomeSecuritiesTaxExempt	1317000	USD
CY2020Q1	us-gaap	Interest Income Securities Tax Exempt InterestIncomeSecuritiesTaxExempt	159000	USD
CY2021Q1	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	17847000	USD
CY2020Q1	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	16506000	USD
CY2021Q1	us-gaap	Interest Expense Domestic Deposits InterestExpenseDomesticDeposits	268000	USD
CY2020Q1	us-gaap	Interest Expense Domestic Deposits InterestExpenseDomesticDeposits	432000	USD
CY2021Q1	us-gaap	Interest Expense Junior Subordinated Debentures InterestExpenseJuniorSubordinatedDebentures	24000	USD
CY2020Q1	us-gaap	Interest Expense Junior Subordinated Debentures InterestExpenseJuniorSubordinatedDebentures	45000	USD
CY2021Q1	us-gaap	Interest Expense Other InterestExpenseOther	0	USD
CY2020Q1	us-gaap	Interest Expense Other InterestExpenseOther	0	USD
CY2020Q1	us-gaap	Interest Income Expense After Provision For Loan Loss InterestIncomeExpenseAfterProvisionForLoanLoss	14654000	USD
CY2021Q1	us-gaap	Interest Expense InterestExpense	292000	USD
CY2020Q1	us-gaap	Interest Expense InterestExpense	477000	USD
CY2021Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	17555000	USD
CY2020Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	16029000	USD
CY2021Q1	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	-1800000	USD
CY2020Q1	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	1375000	USD
CY2021Q1	us-gaap	Interest Income Expense After Provision For Loan Loss InterestIncomeExpenseAfterProvisionForLoanLoss	19355000	USD
CY2021Q1	cvcy	Service Charges ServiceCharges	432000	USD
CY2020Q1	cvcy	Service Charges ServiceCharges	646000	USD
CY2021Q1	us-gaap	Bank Owned Life Insurance Income BankOwnedLifeInsuranceIncome	173000	USD
CY2020Q1	us-gaap	Bank Owned Life Insurance Income BankOwnedLifeInsuranceIncome	182000	USD
CY2021Q1	cvcy	Interchange Fees InterchangeFees	370000	USD
CY2020Q1	cvcy	Interchange Fees InterchangeFees	333000	USD
CY2021Q1	us-gaap	Debt And Equity Securities Gain Loss DebtAndEquitySecuritiesGainLoss	0	USD
CY2020Q1	us-gaap	Debt And Equity Securities Gain Loss DebtAndEquitySecuritiesGainLoss	4198000	USD
CY2021Q1	cvcy	Dividends Federal Home Loan Bank Stocks DividendsFederalHomeLoanBankStocks	70000	USD
CY2020Q1	cvcy	Dividends Federal Home Loan Bank Stocks DividendsFederalHomeLoanBankStocks	107000	USD
CY2021Q1	cvcy	Loan Placement Fees LoanPlacementFees	657000	USD
CY2020Q1	cvcy	Loan Placement Fees LoanPlacementFees	299000	USD
CY2021Q1	us-gaap	Noninterest Income Other Operating Income NoninterestIncomeOtherOperatingIncome	297000	USD
CY2020Q1	us-gaap	Noninterest Income Other Operating Income NoninterestIncomeOtherOperatingIncome	776000	USD
CY2021Q1	us-gaap	Noninterest Income NoninterestIncome	1999000	USD
CY2020Q1	us-gaap	Noninterest Income NoninterestIncome	6541000	USD
CY2021Q1	us-gaap	Labor And Related Expense LaborAndRelatedExpense	6938000	USD
CY2020Q1	us-gaap	Labor And Related Expense LaborAndRelatedExpense	7512000	USD
CY2021Q1	us-gaap	Occupancy Net OccupancyNet	1113000	USD
CY2020Q1	us-gaap	Occupancy Net OccupancyNet	1144000	USD
CY2021Q1	us-gaap	Professional Fees ProfessionalFees	356000	USD
CY2020Q1	us-gaap	Professional Fees ProfessionalFees	458000	USD
CY2021Q1	us-gaap	Information Technology And Data Processing InformationTechnologyAndDataProcessing	617000	USD
CY2020Q1	us-gaap	Information Technology And Data Processing InformationTechnologyAndDataProcessing	336000	USD
CY2021Q1	cvcy	Regulatory Assessments RegulatoryAssessments	161000	USD
CY2020Q1	cvcy	Regulatory Assessments RegulatoryAssessments	47000	USD
CY2021Q1	cvcy	At Mand Debit Card Expenses ATMandDebitCardExpenses	225000	USD
CY2020Q1	cvcy	At Mand Debit Card Expenses ATMandDebitCardExpenses	294000	USD
CY2021Q1	cvcy	Information Technology InformationTechnology	559000	USD
CY2020Q1	cvcy	Information Technology InformationTechnology	608000	USD
CY2021Q1	cvcy	Directors Expenses DirectorsExpenses	41000	USD
CY2020Q1	cvcy	Directors Expenses DirectorsExpenses	192000	USD
CY2021Q1	us-gaap	Advertising Expense AdvertisingExpense	129000	USD
CY2020Q1	us-gaap	Advertising Expense AdvertisingExpense	173000	USD
CY2021Q1	cvcy	Internet Banking Expense InternetBankingExpense	124000	USD
CY2020Q1	cvcy	Internet Banking Expense InternetBankingExpense	196000	USD
CY2021Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	174000	USD
CY2020Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	174000	USD
CY2021Q1	us-gaap	Other Noninterest Expense OtherNoninterestExpense	951000	USD
CY2020Q1	us-gaap	Other Noninterest Expense OtherNoninterestExpense	944000	USD
CY2021Q1	us-gaap	Noninterest Expense NoninterestExpense	11388000	USD
CY2020Q1	us-gaap	Noninterest Expense NoninterestExpense	12078000	USD
CY2021Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	9966000	USD
CY2020Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	9117000	USD
CY2021Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2487000	USD
CY2020Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2494000	USD
CY2021Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	7479000	USD
CY2020Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	6623000	USD
CY2021Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.60
CY2020Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.52
CY2021Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	12495606	shares
CY2020Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	12734971	shares
CY2021Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.60
CY2020Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.52
CY2021Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	12547137	shares
CY2020Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	12779096	shares
CY2021Q1	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.11
CY2020Q1	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.11
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	7479000	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	6623000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	-13621000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	-1687000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax	0	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax	4198000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Before Tax OtherComprehensiveIncomeLossBeforeTax	-13621000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Before Tax OtherComprehensiveIncomeLossBeforeTax	-5885000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	-4027000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	-1740000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-9594000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-4145000	USD
CY2021Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-2115000	USD
CY2020Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	2478000	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	228128000	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	6623000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-4145000	USD
CY2020Q1	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	58000	USD
CY2020Q1	us-gaap	Stock Issued During Period Value Employee Stock Ownership Plan StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan	141000	USD
CY2020Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	121000	USD
CY2020Q1	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	1408000	USD
CY2020Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	207000	USD
CY2020Q1	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	11052000	USD
CY2020Q1	us-gaap	Stockholders Equity StockholdersEquity	218673000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	245021000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	7479000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-9594000	USD
CY2021Q1	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	56000	USD
CY2021Q1	us-gaap	Stock Issued During Period Value Employee Stock Ownership Plan StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan	158000	USD
CY2021Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	101000	USD
CY2021Q1	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	1377000	USD
CY2021Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	1000	USD
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	241845000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	7479000	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	6623000	USD
CY2021Q1	cvcy	Decrease Deferred Loan Costs DecreaseDeferredLoanCosts	559000	USD
CY2020Q1	cvcy	Decrease Deferred Loan Costs DecreaseDeferredLoanCosts	-36000	USD
CY2021Q1	us-gaap	Depreciation Nonproduction DepreciationNonproduction	223000	USD
CY2020Q1	us-gaap	Depreciation Nonproduction DepreciationNonproduction	240000	USD
CY2021Q1	cvcy	Accretion Amortizationof Discountsand Premiums AccretionAmortizationofDiscountsandPremiums	327000	USD
CY2020Q1	cvcy	Accretion Amortizationof Discountsand Premiums AccretionAmortizationofDiscountsandPremiums	338000	USD
CY2021Q1	us-gaap	Adjustment For Amortization AdjustmentForAmortization	1633000	USD
CY2020Q1	us-gaap	Adjustment For Amortization AdjustmentForAmortization	942000	USD
CY2021Q1	us-gaap	Share Based Compensation ShareBasedCompensation	101000	USD
CY2020Q1	us-gaap	Share Based Compensation ShareBasedCompensation	121000	USD
CY2021Q1	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	-1800000	USD
CY2020Q1	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	1375000	USD
CY2021Q1	us-gaap	Availableforsale Securities Gross Realized Gain Loss Excluding Other Than Temporary Impairments AvailableforsaleSecuritiesGrossRealizedGainLossExcludingOtherThanTemporaryImpairments	0	USD
CY2020Q1	us-gaap	Availableforsale Securities Gross Realized Gain Loss Excluding Other Than Temporary Impairments AvailableforsaleSecuritiesGrossRealizedGainLossExcludingOtherThanTemporaryImpairments	4198000	USD
CY2021Q1	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	2000	USD
CY2020Q1	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	0	USD
CY2021Q1	us-gaap	Increase Decrease In Trading Securities IncreaseDecreaseInTradingSecurities	-134000	USD
CY2020Q1	us-gaap	Increase Decrease In Trading Securities IncreaseDecreaseInTradingSecurities	120000	USD
CY2021Q1	us-gaap	Life Insurance Corporate Or Bank Owned Change In Value LifeInsuranceCorporateOrBankOwnedChangeInValue	173000	USD
CY2020Q1	us-gaap	Life Insurance Corporate Or Bank Owned Change In Value LifeInsuranceCorporateOrBankOwnedChangeInValue	182000	USD
CY2021Q1	cvcy	Gain Loss On Bank Owned Life Insurance GainLossOnBankOwnedLifeInsurance	0	USD
CY2020Q1	cvcy	Gain Loss On Bank Owned Life Insurance GainLossOnBankOwnedLifeInsurance	64000	USD
CY2021Q1	cvcy	Increase Decrease In Accrued Interest Receivable And Other Operating Assets Net IncreaseDecreaseInAccruedInterestReceivableAndOtherOperatingAssetsNet	504000	USD
CY2020Q1	cvcy	Increase Decrease In Accrued Interest Receivable And Other Operating Assets Net IncreaseDecreaseInAccruedInterestReceivableAndOtherOperatingAssetsNet	-644000	USD
CY2021Q1	cvcy	Increase Decrease In Interest Payable And Other Operating Liabilities Net IncreaseDecreaseInInterestPayableAndOtherOperatingLiabilitiesNet	69000	USD
CY2020Q1	cvcy	Increase Decrease In Interest Payable And Other Operating Liabilities Net IncreaseDecreaseInInterestPayableAndOtherOperatingLiabilitiesNet	1464000	USD
CY2021Q1	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	-105000	USD
CY2020Q1	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	612000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	144563000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	6379000	USD
CY2020Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	5931000	USD
CY2021Q1	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	84685000	USD
CY2020Q1	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	155742000	USD
CY2021Q1	us-gaap	Proceeds From Sale Of Available For Sale Securities ProceedsFromSaleOfAvailableForSaleSecurities	0	USD
CY2020Q1	us-gaap	Proceeds From Sale Of Available For Sale Securities ProceedsFromSaleOfAvailableForSaleSecurities	106037000	USD
CY2021Q1	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	11331000	USD
CY2020Q1	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	8136000	USD
CY2021Q1	us-gaap	Payments For Proceeds From Loans And Leases PaymentsForProceedsFromLoansAndLeases	-13507000	USD
CY2020Q1	us-gaap	Payments For Proceeds From Loans And Leases PaymentsForProceedsFromLoansAndLeases	-13616000	USD
CY2021Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	344000	USD
CY2020Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	32000	USD
CY2021Q1	us-gaap	Proceeds From Life Insurance Policies ProceedsFromLifeInsurancePolicies	0	USD
CY2020Q1	us-gaap	Proceeds From Life Insurance Policies ProceedsFromLifeInsurancePolicies	531000	USD
CY2021Q1	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	2000	USD
CY2020Q1	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	0	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-60189000	USD
CY2020Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-27454000	USD
CY2021Q1	cvcy	Net Increase Decrease In Demand Interest Bearing And Savings Deposits NetIncreaseDecreaseInDemandInterestBearingAndSavingsDeposits	200112000	USD
CY2020Q1	cvcy	Net Increase Decrease In Demand Interest Bearing And Savings Deposits NetIncreaseDecreaseInDemandInterestBearingAndSavingsDeposits	21196000	USD
CY2021Q1	us-gaap	Increase Decrease In Time Deposits IncreaseDecreaseInTimeDeposits	-419000	USD
CY2020Q1	us-gaap	Increase Decrease In Time Deposits IncreaseDecreaseInTimeDeposits	-3890000	USD
CY2021Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	USD
CY2020Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	11052000	USD
CY2021Q1	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	56000	USD
CY2020Q1	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	58000	USD
CY2021Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	1000	USD
CY2020Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	207000	USD
CY2021Q1	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	1377000	USD
CY2020Q1	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	1408000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	198373000	USD
CY2020Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	5111000	USD
CY2021Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	562000	USD
CY2020Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	559000	USD
CY2020Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-16412000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	70278000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	52574000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	214841000	USD
CY2020Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	36162000	USD
CY2021Q1	us-gaap	Interest Paid Net InterestPaidNet	298000	USD
CY2020Q1	us-gaap	Interest Paid Net InterestPaidNet	502000	USD
CY2021Q1	cvcy	Purchases Of Available For Sale Securities Not Yet Settled PurchasesOfAvailableForSaleSecuritiesNotYetSettled	0	USD
CY2020Q1	cvcy	Purchases Of Available For Sale Securities Not Yet Settled PurchasesOfAvailableForSaleSecuritiesNotYetSettled	12718000	USD
CY2021Q1	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	No customer accounts for more than 10 percent of revenues for the Company or the Bank.
CY2021Q1	us-gaap	Pledged Assets Separately Reported Securities Pledged As Collateral At Fair Value PledgedAssetsSeparatelyReportedSecuritiesPledgedAsCollateralAtFairValue	177938000	USD
CY2021Q1	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Gain Loss Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainLossBeforeTax	7470000	USD
CY2020Q4	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Gain Loss Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainLossBeforeTax	21091000	USD
CY2021Q1	cvcy	Accumulated Other Comprehensive Income Available For Sale Securities Adjustment Tax AccumulatedOtherComprehensiveIncomeAvailableForSaleSecuritiesAdjustmentTax	2208000	USD
CY2020Q4	cvcy	Accumulated Other Comprehensive Income Available For Sale Securities Adjustment Tax AccumulatedOtherComprehensiveIncomeAvailableForSaleSecuritiesAdjustmentTax	6235000	USD
CY2021Q1	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	761249000	USD
CY2021Q1	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	15362000	USD
CY2021Q1	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	7892000	USD
CY2021Q1	us-gaap	Available For Sale Securities AvailableForSaleSecurities	768719000	USD
CY2020Q4	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	689001000	USD
CY2020Q4	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	23371000	USD
CY2020Q4	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	2280000	USD
CY2020Q4	us-gaap	Available For Sale Securities AvailableForSaleSecurities	710092000	USD
CY2021Q1	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	0	USD
CY2020Q1	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	106037000	USD
CY2021Q1	us-gaap	Available For Sale Securities Gross Realized Gains AvailableForSaleSecuritiesGrossRealizedGains	0	USD
CY2020Q1	us-gaap	Available For Sale Securities Gross Realized Gains AvailableForSaleSecuritiesGrossRealizedGains	4198000	USD
CY2021Q1	us-gaap	Available For Sale Securities Gross Realized Losses AvailableForSaleSecuritiesGrossRealizedLosses	0	USD
CY2020Q1	us-gaap	Available For Sale Securities Gross Realized Losses AvailableForSaleSecuritiesGrossRealizedLosses	0	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax	1241000	USD
CY2021Q1	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months	276378000	USD
CY2021Q1	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	7177000	USD
CY2021Q1	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger	74067000	USD
CY2021Q1	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	715000	USD
CY2021Q1	us-gaap	Debt Securities Available For Sale Unrealized Loss Position DebtSecuritiesAvailableForSaleUnrealizedLossPosition	350445000	USD
CY2021Q1	us-gaap	Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss	7892000	USD
CY2020Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months	105252000	USD
CY2020Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	1085000	USD
CY2020Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger	81237000	USD
CY2020Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	1195000	USD
CY2020Q4	us-gaap	Debt Securities Available For Sale Unrealized Loss Position DebtSecuritiesAvailableForSaleUnrealizedLossPosition	186489000	USD
CY2020Q4	us-gaap	Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss	2280000	USD
CY2021Q1	cvcy	Threshold Period Of Value Decline In Available For Sale Securities To Be Considered Other Than Temporary Impairment ThresholdPeriodOfValueDeclineInAvailableForSaleSecuritiesToBeConsideredOtherThanTemporaryImpairment	P12M
CY2021Q1	cvcy	Threshold Percentage Of Value Decline In Available For Sale Securities To Be Considered Other Than Temporary Impairment ThresholdPercentageOfValueDeclineInAvailableForSaleSecuritiesToBeConsideredOtherThanTemporaryImpairment	0.10
CY2021Q1	cvcy	Threshold Amount Of Value Decline In Available For Sale Securities To Be Considered Other Than Temporary Impairment ThresholdAmountOfValueDeclineInAvailableForSaleSecuritiesToBeConsideredOtherThanTemporaryImpairment	75000	USD
CY2021Q1	us-gaap	Impairment Of Investments ImpairmentOfInvestments	0	USD
CY2021Q1	cvcy	Available For Sale Securities Number Of Securities Loss Position AvailableForSaleSecuritiesNumberOfSecuritiesLossPosition	4	Loans
CY2021Q1	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	301000	USD
CY2021Q1	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	305000	USD
CY2021Q1	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost	3285000	USD
CY2021Q1	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	3612000	USD
CY2021Q1	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost	24932000	USD
CY2021Q1	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue	26876000	USD
CY2021Q1	us-gaap	Available For Sale Securities Debt Maturities After Ten Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost	379670000	USD
CY2021Q1	us-gaap	Available For Sale Securities Debt Maturities After Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue	382690000	USD
CY2021Q1	cvcy	Available For Sale Securities Debt Maturities With Single Maturity Date Amortized Cost Basis AvailableForSaleSecuritiesDebtMaturitiesWithSingleMaturityDateAmortizedCostBasis	408188000	USD
CY2021Q1	cvcy	Available For Sale Securities Debt Maturities With Single Maturity Date Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithSingleMaturityDateFairValue	413483000	USD
CY2021Q1	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	761249000	USD
CY2021Q1	us-gaap	Available For Sale Securities AvailableForSaleSecurities	768719000	USD
CY2021Q1	us-gaap	Unamortized Loan Commitment And Origination Fees And Unamortized Discounts Or Premiums UnamortizedLoanCommitmentAndOriginationFeesAndUnamortizedDiscountsOrPremiums	-3171000	USD
CY2020Q4	us-gaap	Unamortized Loan Commitment And Origination Fees And Unamortized Discounts Or Premiums UnamortizedLoanCommitmentAndOriginationFeesAndUnamortizedDiscountsOrPremiums	-2612000	USD
CY2021Q1	us-gaap	Loans And Leases Receivable Gross Carrying Amount LoansAndLeasesReceivableGrossCarryingAmount	1090340000	USD
CY2021Q1	cvcy	Loans And Leases Receivable Percentage Of Gross Loans LoansAndLeasesReceivablePercentageOfGrossLoans	1.000
CY2020Q4	us-gaap	Loans And Leases Receivable Gross Carrying Amount LoansAndLeasesReceivableGrossCarryingAmount	1102347000	USD
CY2020Q4	cvcy	Loans And Leases Receivable Percentage Of Gross Loans LoansAndLeasesReceivablePercentageOfGrossLoans	1.000
CY2021Q1	us-gaap	Loans And Leases Receivable Allowance LoansAndLeasesReceivableAllowance	12056000	USD
CY2020Q4	us-gaap	Loans And Leases Receivable Allowance LoansAndLeasesReceivableAllowance	12915000	USD
CY2021Q1	us-gaap	Loans And Leases Receivable Net Reported Amount LoansAndLeasesReceivableNetReportedAmount	1078284000	USD
CY2020Q4	us-gaap	Loans And Leases Receivable Net Reported Amount LoansAndLeasesReceivableNetReportedAmount	1089432000	USD
CY2021Q1	cvcy	Loansand Leases Receivable Allowance Numberof Components LoansandLeasesReceivableAllowanceNumberofComponents	2	component
CY2021Q1	cvcy	Financing Receivable Allowance For Credit Losses Methodology Change Number Of Rolling Quarters Used In Analysis FinancingReceivableAllowanceForCreditLossesMethodologyChangeNumberOfRollingQuartersUsedInAnalysis	49	quarter
CY2020Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	12915000	USD
CY2021Q1	us-gaap	Provision For Loan Lease And Other Losses ProvisionForLoanLeaseAndOtherLosses	1800000	USD
CY2021Q1	us-gaap	Financing Receivable Allowance For Credit Losses Write Offs FinancingReceivableAllowanceForCreditLossesWriteOffs	57000	USD
CY2021Q1	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	12056000	USD
CY2021Q1	us-gaap	Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1 FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1	1259000	USD
CY2021Q1	us-gaap	Financing Receivable Allowance For Credit Losses Recovery FinancingReceivableAllowanceForCreditLossesRecovery	998000	USD
CY2021Q1	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	12056000	USD
CY2019Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	9130000	USD
CY2020Q1	us-gaap	Provision For Loan Lease And Other Losses ProvisionForLoanLeaseAndOtherLosses	1375000	USD
CY2020Q1	us-gaap	Financing Receivable Allowance For Credit Losses Write Offs FinancingReceivableAllowanceForCreditLossesWriteOffs	43000	USD
CY2020Q1	us-gaap	Financing Receivable Allowance For Credit Losses Recovery FinancingReceivableAllowanceForCreditLossesRecovery	84000	USD
CY2020Q1	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	10546000	USD
CY2021Q1	us-gaap	Financing Receivable Allowance For Credit Losses Collectively Evaluated For Impairment FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment	10797000	USD
CY2020Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	12915000	USD
CY2020Q4	us-gaap	Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1 FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1	631000	USD
CY2020Q4	us-gaap	Financing Receivable Allowance For Credit Losses Collectively Evaluated For Impairment FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment	12284000	USD
CY2021Q1	us-gaap	Notes Receivable Gross NotesReceivableGross	1093511000	USD
CY2021Q1	us-gaap	Financing Receivable Individually Evaluated For Impairment FinancingReceivableIndividuallyEvaluatedForImpairment	11006000	USD
CY2021Q1	us-gaap	Financing Receivable Collectively Evaluated For Impairment FinancingReceivableCollectivelyEvaluatedForImpairment	1082505000	USD
CY2020Q4	us-gaap	Notes Receivable Gross NotesReceivableGross	1104959000	USD
CY2020Q4	us-gaap	Financing Receivable Individually Evaluated For Impairment FinancingReceivableIndividuallyEvaluatedForImpairment	11186000	USD
CY2020Q4	us-gaap	Financing Receivable Collectively Evaluated For Impairment FinancingReceivableCollectivelyEvaluatedForImpairment	1093773000	USD
CY2021Q1	us-gaap	Notes Receivable Gross NotesReceivableGross	1093511000	USD
CY2020Q4	us-gaap	Notes Receivable Gross NotesReceivableGross	1104959000	USD
CY2021Q1	us-gaap	Financing Receivable Recorded Investment Past Due FinancingReceivableRecordedInvestmentPastDue	0	USD
CY2021Q1	us-gaap	Financing Receivable Recorded Investment Current FinancingReceivableRecordedInvestmentCurrent	1093511000	USD
CY2021Q1	us-gaap	Notes Receivable Gross NotesReceivableGross	1093511000	USD
CY2021Q1	us-gaap	Financing Receivable Recorded Investment90 Days Past Due And Still Accruing FinancingReceivableRecordedInvestment90DaysPastDueAndStillAccruing	0	USD
CY2021Q1	us-gaap	Financing Receivable Recorded Investment Nonaccrual Status FinancingReceivableRecordedInvestmentNonaccrualStatus	3783000	USD
CY2020Q4	us-gaap	Financing Receivable Recorded Investment Past Due FinancingReceivableRecordedInvestmentPastDue	89000	USD
CY2020Q4	us-gaap	Financing Receivable Recorded Investment Current FinancingReceivableRecordedInvestmentCurrent	1104870000	USD
CY2020Q4	us-gaap	Notes Receivable Gross NotesReceivableGross	1104959000	USD
CY2020Q4	us-gaap	Financing Receivable Recorded Investment90 Days Past Due And Still Accruing FinancingReceivableRecordedInvestment90DaysPastDueAndStillAccruing	0	USD
CY2020Q4	us-gaap	Financing Receivable Recorded Investment Nonaccrual Status FinancingReceivableRecordedInvestmentNonaccrualStatus	3278000	USD
CY2021Q1	us-gaap	Impaired Financing Receivable With No Related Allowance Recorded Investment ImpairedFinancingReceivableWithNoRelatedAllowanceRecordedInvestment	991000	USD
CY2021Q1	us-gaap	Impaired Financing Receivable With No Related Allowance Unpaid Principal Balance ImpairedFinancingReceivableWithNoRelatedAllowanceUnpaidPrincipalBalance	1083000	USD
CY2021Q1	us-gaap	Impaired Financing Receivable With Related Allowance Recorded Investment ImpairedFinancingReceivableWithRelatedAllowanceRecordedInvestment	10015000	USD
CY2021Q1	us-gaap	Impaired Financing Receivable With Related Allowance Unpaid Principal Balance ImpairedFinancingReceivableWithRelatedAllowanceUnpaidPrincipalBalance	10115000	USD
CY2021Q1	us-gaap	Impaired Financing Receivable Related Allowance ImpairedFinancingReceivableRelatedAllowance	1259000	USD
CY2021Q1	us-gaap	Impaired Financing Receivable Recorded Investment ImpairedFinancingReceivableRecordedInvestment	11006000	USD
CY2021Q1	us-gaap	Impaired Financing Receivable Unpaid Principal Balance ImpairedFinancingReceivableUnpaidPrincipalBalance	11198000	USD
CY2021Q1	us-gaap	Impaired Financing Receivable Related Allowance ImpairedFinancingReceivableRelatedAllowance	1259000	USD
CY2020Q4	us-gaap	Impaired Financing Receivable With No Related Allowance Recorded Investment ImpairedFinancingReceivableWithNoRelatedAllowanceRecordedInvestment	1114000	USD
CY2020Q4	us-gaap	Impaired Financing Receivable With No Related Allowance Unpaid Principal Balance ImpairedFinancingReceivableWithNoRelatedAllowanceUnpaidPrincipalBalance	1239000	USD
CY2020Q4	us-gaap	Impaired Financing Receivable With Related Allowance Recorded Investment ImpairedFinancingReceivableWithRelatedAllowanceRecordedInvestment	10072000	USD
CY2020Q4	us-gaap	Impaired Financing Receivable With Related Allowance Unpaid Principal Balance ImpairedFinancingReceivableWithRelatedAllowanceUnpaidPrincipalBalance	10132000	USD
CY2020Q4	us-gaap	Impaired Financing Receivable Related Allowance ImpairedFinancingReceivableRelatedAllowance	631000	USD
CY2020Q4	us-gaap	Impaired Financing Receivable Recorded Investment ImpairedFinancingReceivableRecordedInvestment	11186000	USD
CY2020Q4	us-gaap	Impaired Financing Receivable Unpaid Principal Balance ImpairedFinancingReceivableUnpaidPrincipalBalance	11371000	USD
CY2020Q4	us-gaap	Impaired Financing Receivable Related Allowance ImpairedFinancingReceivableRelatedAllowance	631000	USD
CY2021Q1	us-gaap	Impaired Financing Receivable With No Related Allowance Average Recorded Investment ImpairedFinancingReceivableWithNoRelatedAllowanceAverageRecordedInvestment	952000	USD
CY2021Q1	us-gaap	Impaired Financing Receivable With No Related Allowance Interest Income Accrual Method ImpairedFinancingReceivableWithNoRelatedAllowanceInterestIncomeAccrualMethod	12000	USD
CY2020Q1	us-gaap	Impaired Financing Receivable With No Related Allowance Average Recorded Investment ImpairedFinancingReceivableWithNoRelatedAllowanceAverageRecordedInvestment	2193000	USD
CY2020Q1	us-gaap	Impaired Financing Receivable With No Related Allowance Interest Income Accrual Method ImpairedFinancingReceivableWithNoRelatedAllowanceInterestIncomeAccrualMethod	15000	USD
CY2021Q1	us-gaap	Impaired Financing Receivable With Related Allowance Average Recorded Investment ImpairedFinancingReceivableWithRelatedAllowanceAverageRecordedInvestment	10386000	USD
CY2021Q1	us-gaap	Impaired Financing Receivable With Related Allowance Interest Income Accrual Method ImpairedFinancingReceivableWithRelatedAllowanceInterestIncomeAccrualMethod	650000	USD
CY2020Q1	us-gaap	Impaired Financing Receivable With Related Allowance Average Recorded Investment ImpairedFinancingReceivableWithRelatedAllowanceAverageRecordedInvestment	4557000	USD
CY2020Q1	us-gaap	Impaired Financing Receivable With Related Allowance Interest Income Accrual Method ImpairedFinancingReceivableWithRelatedAllowanceInterestIncomeAccrualMethod	202000	USD
CY2021Q1	us-gaap	Impaired Financing Receivable Average Recorded Investment ImpairedFinancingReceivableAverageRecordedInvestment	11338000	USD
CY2021Q1	us-gaap	Impaired Financing Receivable Interest Income Accrual Method ImpairedFinancingReceivableInterestIncomeAccrualMethod	662000	USD
CY2020Q1	us-gaap	Impaired Financing Receivable Average Recorded Investment ImpairedFinancingReceivableAverageRecordedInvestment	6750000	USD
CY2020Q1	us-gaap	Impaired Financing Receivable Interest Income Accrual Method ImpairedFinancingReceivableInterestIncomeAccrualMethod	217000	USD
CY2021Q1	us-gaap	Loans And Leases Receivable Impaired Interest Lost On Nonaccrual Loans LoansAndLeasesReceivableImpairedInterestLostOnNonaccrualLoans	56000	USD
CY2020Q1	us-gaap	Loans And Leases Receivable Impaired Interest Lost On Nonaccrual Loans LoansAndLeasesReceivableImpairedInterestLostOnNonaccrualLoans	24000	USD
CY2021Q1	us-gaap	Financing Receivable Modifications Recorded Investment FinancingReceivableModificationsRecordedInvestment	7223000	USD
CY2020Q4	us-gaap	Financing Receivable Modifications Recorded Investment FinancingReceivableModificationsRecordedInvestment	7908000	USD
CY2021Q1	cvcy	Financing Receivable Modifications Related Allowance FinancingReceivableModificationsRelatedAllowance	590000	USD
CY2020Q4	cvcy	Financing Receivable Modifications Related Allowance FinancingReceivableModificationsRelatedAllowance	20000	USD
CY2021Q1	us-gaap	Financing Receivable Modifications Number Of Contracts2 FinancingReceivableModificationsNumberOfContracts2	1	Loans
CY2021Q1	cvcy	Financing Receivable Modifications Subsequent Defaults During Period Number Of Contracts FinancingReceivableModificationsSubsequentDefaultsDuringPeriodNumberOfContracts	0	contract
CY2020Q1	cvcy	Financing Receivable Modifications Subsequent Defaults During Period Number Of Contracts FinancingReceivableModificationsSubsequentDefaultsDuringPeriodNumberOfContracts	0	contract
CY2021Q1	us-gaap	Goodwill Goodwill	53777000	USD
CY2021Q1	us-gaap	Federal Funds Purchased FederalFundsPurchased	0	USD
CY2020Q4	us-gaap	Federal Funds Purchased FederalFundsPurchased	0	USD
CY2021Q1	us-gaap	Other Commitment OtherCommitment	2475000	USD
CY2021Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	7479000	USD
CY2020Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	6623000	USD
CY2021Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	12495606	shares
CY2020Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	12734971	shares
CY2021Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.60
CY2020Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.52
CY2021Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	7479000	USD
CY2020Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	6623000	USD
CY2021Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	12495606	shares
CY2021Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	0	shares
CY2020Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	12734971	shares
CY2021Q1	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	51531	shares
CY2020Q1	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	44125	shares
CY2021Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	12547137	shares
CY2020Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	12779096	shares
CY2021Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.60
CY2020Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.52
CY2020Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	0	shares
CY2021Q1	cvcy	Sharebased Compensation Arrangementby Sharebased Payment Award Numberof Plans SharebasedCompensationArrangementbySharebasedPaymentAwardNumberofPlans	4	plan
CY2021Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	101000	USD
CY2020Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	121000	USD
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	77070	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	10.06
CY2021Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	100	shares
CY2021Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	8.02
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	76970	shares
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	10.06
CY2021Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P1Y3M7D
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	653000	USD
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	76970	shares
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	10.06
CY2021Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P1Y3M7D
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	653000	USD
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber	76970	shares
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice	10.06
CY2021Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1	P1Y3M7D
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue	653000	USD
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	1000	USD
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	349000	USD
CY2021Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	1000	USD
CY2020Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	207000	USD
CY2021Q1	us-gaap	Employee Service Share Based Compensation Tax Benefit From Exercise Of Stock Options EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions	0	USD
CY2020Q1	us-gaap	Employee Service Share Based Compensation Tax Benefit From Exercise Of Stock Options EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions	72000	USD
CY2021Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	0	USD

Files In Submission

Name	View Source	Status
0001127371-21-000063-index-headers.html	Edgar Link	pending
0001127371-21-000063-index.html	Edgar Link	pending
0001127371-21-000063.txt	Edgar Link	pending
0001127371-21-000063-xbrl.zip	Edgar Link	pending
cvcy-20210331.htm	Edgar Link	pending
cvcy-20210331.xsd	Edgar Link	pending
cvcy-20210331_cal.xml	Edgar Link	unprocessable
cvcy-20210331_def.xml	Edgar Link	unprocessable
cvcy-20210331_htm.xml	Edgar Link	completed
cvcy-20210331_lab.xml	Edgar Link	unprocessable
cvcy-20210331_pre.xml	Edgar Link	unprocessable
exhibit3112021q1-ng11.htm	Edgar Link	pending
exhibit3122021q1-ng11.htm	Edgar Link	pending
exhibit3212021q1-ng11.htm	Edgar Link	pending
exhibit3222021q1-ng11.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CWBC
Community West Bancshares Stock $cwbc

2021 Q1 Form 10-Q Financial Statement

#000112737121000063 Filed on May 05, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CWBC Community West Bancshares Stock $cwbc

2021 Q1 Form 10-Q Financial Statement

#000112737121000063 Filed on May 05, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CWBC
Community West Bancshares Stock $cwbc